HLA DR–DQ associations with cervical carcinoma show papillomavirus–type specificity

[1]  W. Klitz,et al.  Localization of predisposition to Hodgkin disease in the HLA class II region. , 1994, American journal of human genetics.

[2]  C. Wheeler,et al.  Determinants of Genital Human Papillomavirus Infection Among Cytologically Normal Women Attending the University of New Mexico Student Health Center , 1993, Sexually transmitted diseases.

[3]  P. Stern,et al.  Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer. , 1993, Human immunology.

[4]  S Wacholder,et al.  Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. , 1993, Journal of the National Cancer Institute.

[5]  Henry A. Erlich,et al.  HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families , 1993, Nature Genetics.

[6]  C. Vandenvelde,et al.  HLA-DQB1 *03 and cervical intraepithelial neoplasia grades I-III , 1993, The Lancet.

[7]  M. Aidoo,et al.  Molecular analysis of the association of HLA-B53 and resistance to severe malaria , 1992, Nature.

[8]  K. Holmes,et al.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection , 1992, The New England journal of medicine.

[9]  H. Bernard,et al.  Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses , 1992, Journal of virology.

[10]  H. Erlich,et al.  Two new HLA DRB1 alleles found in African Americans: implications for balancing selection at positions 57 and 86. , 1992, Tissue antigens.

[11]  M. Seif,et al.  HLA-DQB103 and cervical intraepithelial neoplasia type III , 1992, The Lancet.

[12]  J. Samet,et al.  Cervical cancer incidence and mortality in New Mexico's Hispanics, American Indians, and non-Hispanic whites. , 1992, The Western journal of medicine.

[13]  G. Orth,et al.  Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class II genes , 1992, Nature.

[14]  G. Higgins,et al.  Alzheimer's retraction , 1992, Nature.

[15]  P. Stern,et al.  HLA antigens and cervical carcinoma , 1992, Nature.

[16]  R Reid,et al.  Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. , 1992, Obstetrics and gynecology.

[17]  W. Klitz,et al.  Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. , 1992, Journal of immunology.

[18]  Schiffman Mh.  Validation of hybridization assays: correlation of filter in situ, dot blot and PCR with Southern blot. , 1992 .

[19]  Brinton La.  Epidemiology of cervical cancer--overview. , 1992 .

[20]  C. Thomssen,et al.  High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3 , 1991, Nature.

[21]  Andrew J. McMichael,et al.  Common West African HLA antigens are associated with protection from severe malaria , 1991, Nature.

[22]  A. Reingold,et al.  Genital human papillomavirus infection in female university students as determined by a PCR‐based method , 1991, JAMA.

[23]  L. Chen,et al.  Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. Erlich,et al.  Rapid typing of DNA sequence polymorphism at the HLA-DRB1 locus using the polymerase chain reaction and nonradioactive oligonucleotide probes. , 1991, Human immunology.

[25]  H. Erlich,et al.  MHC class-II molecules and autoimmunity. , 1991, Annual review of immunology.

[26]  N. Day,et al.  Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA regions , 1990, Nature.

[27]  A. Levine,et al.  Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.

[28]  G. Temple,et al.  Temporal associations of human papillomavirus infection with cervical cytologic abnormalities. , 1990, American journal of obstetrics and gynecology.

[29]  J. Rothbard,et al.  Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity. , 1990, The Journal of general virology.

[30]  E. Villiers.  Heterogeneity of the human papillomavirus group. , 1989 .

[31]  J. Carmichael,et al.  Cervical dysplasia and human papillomavirus. , 1989, American journal of obstetrics and gynecology.

[32]  K. Münger,et al.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.

[33]  K. Holmes,et al.  Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic. , 1989, The Journal of infectious diseases.

[34]  Steven Wolinsky,et al.  The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses , 1989 .

[35]  Henry A. Erlich,et al.  Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes , 1986, Nature.

[36]  B. Henderson,et al.  Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County. , 1986, Journal of the National Cancer Institute.

[37]  L. Brinton,et al.  Case control study of cervical cancer in Herrera Province, Republic of Panama , 1985, International journal of cancer.

[38]  M. Yaniv,et al.  Papillomavirus genomes: sequences and consequences. , 1984, The Journal of investigative dermatology.